Shilpa Medicare’s finished dosage formulation facility gets GMP certification from Russian Federation

28 May 2021 Evaluate

Shilpa Medicare’s finished dosage formulation facility (Sterile and Non-sterile) located at S-20 to S-26, Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India has been issued GMP certification by the Ministry of Industry and Trade of the Russian Federation for the GMP inspection held from February 22, 2021 to February 26, 2021. There were No Critical, Major and Minor observations found during GMP inspection process. The GMP certificate is valid for three years until April 2024.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

287.40 -2.55 (-0.88%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×